Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

BACKGROUND: The course of autosomal dominant polycystic kidney disease (ADPKD) is often associated with pain, hypertension, and kidney failure. Preclinical studies indicated that vasopressin V(2)-receptor antagonists inhibit cyst growth and slow the decline of kidney function. METHODS: In this phase...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Torres, Vicente E., Chapman, Arlene B., Devuyst, Olivier, Gansevoort, Ron T., Grantham, Jared J., Higashihara, Eiji, Perrone, Ronald D., Krasa, Holly B., Ouyang, John, Czerwiec, Frank S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2012
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3760207/
https://ncbi.nlm.nih.gov/pubmed/23121377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1205511
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items